Literature DB >> 16330720

Psychosocial disability in the course of bipolar I and II disorders: a prospective, comparative, longitudinal study.

Lewis L Judd1, Hagop S Akiskal, Pamela J Schettler, Jean Endicott, Andrew C Leon, David A Solomon, William Coryell, Jack D Maser, Martin B Keller.   

Abstract

CONTEXT: Evidence of psychosocial disability in bipolar disorder is based primarily on bipolar I disorder (BP-I) and does not relate disability to affective symptom severity and polarity or to bipolar II disorder (BP-II).
OBJECTIVE: To provide detailed data on psychosocial disability in relation to symptom status during the long-term course of BP-I and BP-II.
DESIGN: A naturalistic study with 20 years of prospective, systematic follow-up.
SETTING: Inpatient and outpatient treatment facilities at 5 US academic centers. Patients One hundred fifty-eight patients with BP-I and 133 patients with BP-II who were followed up for a mean (SD) of 15 (4.8) years in the National Institute of Mental Health Collaborative Depression Study. MAIN OUTCOME MEASURES: The relationship, by random regression, between Range of Impaired Functioning Tool psychosocial impairment scores and affective symptom status in 1-month periods during the long-term course of illness from 6-month and yearly Longitudinal Interval Follow-up Evaluation interviews.
RESULTS: Psychosocial impairment increases significantly with each increment in depressive symptom severity for BP-I and BP-II and with most increments in manic symptom severity for BP-I. Subsyndromal hypomanic symptoms are not disabling in BP-II, and they may even enhance functioning. Depressive symptoms are at least as disabling as manic or hypomanic symptoms at corresponding severity levels and, in some cases, significantly more so. At each level of depressive symptom severity, BP-I and BP-II are equally impairing. When asymptomatic, patients with bipolar disorder have good psychosocial functioning, although it is not as good as that of well controls.
CONCLUSIONS: Psychosocial disability fluctuates in parallel with changes in affective symptom severity in BP-I and BP-II. Important findings for clinical management are the following: (1) depressive episodes and symptoms, which dominate the course of BP-I and BP-II, are equal to or more disabling than corresponding levels of manic or hypomanic symptoms; (2) subsyndromal depressive symptoms, but not subsyndromal manic or hypomanic symptoms, are associated with significant impairment; and (3) subsyndromal hypomanic symptoms appear to enhance functioning in BP-II.

Entities:  

Mesh:

Year:  2005        PMID: 16330720     DOI: 10.1001/archpsyc.62.12.1322

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  142 in total

1.  Prevalence and clinical significance of subsyndromal manic symptoms, including irritability and psychomotor agitation, during bipolar major depressive episodes.

Authors:  Lewis L Judd; Pamela J Schettler; Hagop Akiskal; William Coryell; Jan Fawcett; Jess G Fiedorowicz; David A Solomon; Martin B Keller
Journal:  J Affect Disord       Date:  2012-02-06       Impact factor: 4.839

Review 2.  CNVs: harbingers of a rare variant revolution in psychiatric genetics.

Authors:  Dheeraj Malhotra; Jonathan Sebat
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

Review 3.  Body dysmorphic disorder: some key issues for DSM-V.

Authors:  Katharine A Phillips; Sabine Wilhelm; Lorrin M Koran; Elizabeth R Didie; Brian A Fallon; Jamie Feusner; Dan J Stein
Journal:  Depress Anxiety       Date:  2010-06       Impact factor: 6.505

4.  Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depression.

Authors:  David E Kemp; Stephen J Ganocy; Martin Brecher; Berit X Carlson; Suzanne Edwards; James M Eudicone; Gary Evoniuk; Wim Jansen; Andrew C Leon; Margaret Minkwitz; Andrei Pikalov; Hans H Stassen; Armin Szegedi; Mauricio Tohen; Arjen P P Van Willigenburg; Joseph R Calabrese
Journal:  J Affect Disord       Date:  2010-11-10       Impact factor: 4.839

Review 5.  Functional impairment, stress, and psychosocial intervention in bipolar disorder.

Authors:  David J Miklowitz
Journal:  Curr Psychiatry Rep       Date:  2011-12       Impact factor: 5.285

6.  Emotion in bipolar I disorder: Implications for functional and symptom outcomes.

Authors:  Sheri L Johnson; Jordan A Tharp; Andrew D Peckham; Kaja J McMaster
Journal:  J Abnorm Psychol       Date:  2015-10-19

Review 7.  Bipolar Depression and Cognitive Impairment: Shared Mechanisms and New Treatment Avenues.

Authors:  Colin A Depp; Sheena Dev; Lisa T Eyler
Journal:  Psychiatr Clin North Am       Date:  2015-12-11

8.  Assessing cognitive function in bipolar disorder: challenges and recommendations for clinical trial design.

Authors:  Katherine E Burdick; Terence A Ketter; Joseph F Goldberg; Joseph R Calabrese
Journal:  J Clin Psychiatry       Date:  2015-03       Impact factor: 4.384

9.  Correlates of recovery of social functioning in types I and II bipolar disorder patients.

Authors:  Aliza P Wingo; Ross J Baldessarini; Michael T Compton; Philip D Harvey
Journal:  Psychiatry Res       Date:  2010-03-23       Impact factor: 3.222

10.  An Integrated Risk Reduction Intervention can reduce body mass index in individuals being treated for bipolar I disorder: results from a randomized trial.

Authors:  Ellen Frank; Meredith L Wallace; Martica Hall; Brant Hasler; Jessica C Levenson; Carol A Janney; Isabella Soreca; Matthew C Fleming; Joan Buttenfield; Fiona C Ritchey; David J Kupfer
Journal:  Bipolar Disord       Date:  2014-12-12       Impact factor: 6.744

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.